Pyrrolidine-pyrazole ureas as potent and selective inhibitors of 11β-hydroxysteroid-dehydrogenase type 1
- 1 April 2011
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (8) , 2244-2251
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetesThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- Efficacious 11β-Hydroxysteroid Dehydrogenase Type I Inhibitors in the Diet-Induced Obesity Mouse ModelJournal of Medicinal Chemistry, 2009
- Two Asymmetric Syntheses of AMG 221, an Inhibitor of 11β-Hydroxysteroid Dehydrogenase Type 1The Journal of Organic Chemistry, 2009
- Bioisosteric replacement of the pyrazole 3-carboxamide moiety of rimonabant. A novel series of oxadiazoles as CB1 cannabinoid receptor antagonistsOrganic & Biomolecular Chemistry, 2008
- Discovery and biological evaluation of adamantyl amide 11β-HSD1 inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Adamantyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1Bioorganic & Medicinal Chemistry Letters, 2005
- Identification of nonpeptidic small-molecule inhibitors of interleukin-2Bioorganic & Medicinal Chemistry Letters, 2005
- Expression of the mRNA Coding for 11 -Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue from Obese Patients: An in Situ Hybridization StudyThe Journal of Clinical Endocrinology & Metabolism, 2002
- Studies on New Platelet Aggregation Inhibitors 1. Synthesis of 7-Nitro-3,4-dihydroquinoline-2(1H)-one Derivatives.Chemical and Pharmaceutical Bulletin, 2001
- Synthesis and potential antipsychotic activity of 1H-imidazo[1,2-c]pyrazolo[3,4-e]pyrimidinesJournal of Medicinal Chemistry, 1988